Stay updated with breaking news from Eric Benevich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) – Stock analysts at Cantor Fitzgerald decreased their FY2023 EPS estimates for Neurocrine Biosciences in a research report issued to clients and investors on Tuesday, February 7th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of $3.58 per share for the year, down […]
Operator: Good day, everyone, and welcome to today's Neurocrine Biosciences Reports Fourth Quarter and Year End Results. At this time, all participants are in a listen-only mode.
NBIX earnings call for the period ending June 30, 2022.
Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...
NBIX earnings call for the period ending December 31, 2021.